Zeke Capital Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $563K | Buy |
6,561
+116
| +2% | +$9.96K | 0.04% | 223 |
|
|
2022
Q3 | $397K | Buy |
6,445
+114
| +2% | +$7.02K | 0.03% | 250 |
|
|
2022
Q2 | $392K | Sell |
6,331
-130
| -2% | -$8.05K | 0.03% | 259 |
|
|
2022
Q1 | $385K | Buy |
+6,461
| New | +$385K | 0.02% | 291 |
|
|
2020
Q1 | – | Sell |
-36,044
| Closed | -$2.34M | – | 349 |
|
|
2019
Q4 | $2.34M | Buy |
36,044
+21,872
| +154% | +$1.42M | 0.19% | 98 |
|
|
2019
Q3 | $898K | Sell |
14,172
-9,014
| -39% | -$571K | 0.08% | 214 |
|
|
2019
Q2 | $1.57M | Buy |
23,186
+775
| +3% | +$52.3K | 0.15% | 127 |
|
|
2019
Q1 | $1.46M | Buy |
22,411
+2,874
| +15% | +$187K | 0.14% | 131 |
|
|
2018
Q4 | $1.22M | Buy |
19,537
+1,536
| +9% | +$96.1K | 0.12% | 161 |
|
|
2018
Q3 | $1.39M | Buy |
18,001
+4,219
| +31% | +$326K | 0.11% | 168 |
|
|
2018
Q2 | $976K | Sell |
13,782
-20,241
| -59% | -$1.43M | 0.09% | 189 |
|
|
2018
Q1 | $2.57M | Buy |
34,023
+16,473
| +94% | +$1.24M | 0.24% | 75 |
|
|
2017
Q4 | $1.26M | Sell |
17,550
-6,422
| -27% | -$460K | 0.13% | 136 |
|
|
2017
Q3 | $1.94M | Buy |
23,972
+14,730
| +159% | +$1.19M | 0.27% | 66 |
|
|
2017
Q2 | $654K | Sell |
9,242
-6,537
| -41% | -$463K | 0.13% | 102 |
|
|
2017
Q1 | $1.07M | Buy |
15,779
+4,255
| +37% | +$289K | 0.22% | 58 |
|
|
2016
Q4 | $825K | Buy |
11,524
+8,773
| +319% | +$628K | 0.22% | 49 |
|
|
2016
Q3 | $204K | Buy |
+2,751
| New | +$204K | 0.09% | 82 |
|